ProPhase Labs reported that Jason Karkus became President of Nebula Genomics, a wholly-owned subsidiary of ProPhase Labs. In his new role, Karkus aims to amplify the Nebula Genomics business-to-business operations, as well as its exciting direct-to-consumer Whole Genome Sequencing model. This strategic move is in line with ProPhase’s evolution from a high complexity molecular Covid testing laboratory to an advanced WGS pioneer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PRPH: